Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 43, pseudogene (RN7SL43P)

Target
RN7SL43P
Molecular classification
Pseudogene (specifically, a non-coding RNA pseudogene), Homologous to signal recognition particle RNA (SRP RNA family)
01

Overview

RNA, 7SL, cytoplasmic 43, pseudogene (RN7SL43P) is an annotated pseudogene in the human genome related by sequence similarity to the functional 7SL RNA, a critical non-coding RNA component of the signal recognition particle (SRP). Pseudogenes like RN7SL43P result from ancient duplication or retrotransposition events and are defined by their incapacity to produce a functional product, as outlined in HGNC guidelines[4][6]. While the functional 7SL RNA has significant roles in protein targeting, translation regulation, and cancer biology, RN7SL43P itself does not possess biological activity, and there is no evidence supporting its role as a disease driver, drug target, or biomarker[2][4][6].

Other names
RN7SL43PRNA, 7SL, cytoplasmic 43, pseudogeneAlso related by homology to: 7SL RNA, SRP RNA, RNA, 7SL, cytoplasmic 1 (RN7SL1)
02

Mechanism of action

Not applicable; no drugs target RN7SL43P[2][4]

03

Biological functions

None known for RN7SL43P directly; it does not produce a functional product[2][4][6]The functional ancestor (7SL RNA) plays roles in SRP complex assembly, protein targeting to the endoplasmic reticulum, regulation of translation, and modulating p53 signaling in cancer[1][3][5]
04

Disease associations

None known for RN7SL43PThe functional ancestor (7SL RNA, RN7SL1) is upregulated in cancers and implicated in modulation of tumor suppressors such as p53[1][3]
05

Safety considerations

None documented for RN7SL43P.Pseudogenes in general do not express functional products and thus are not typically associated with adverse safety profiles[4][6]
06

Interacting drugs

None known for RN7SL43P. No drugs are documented to interact with this pseudogene[2][4][6]
07

Biomarkers

Not applicable for RN7SL43PFunctional 7SL RNA (not the pseudogene) has been explored as a biomarker in cancer[1][3]

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 43, pseudogene (RN7SL43P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 43, pseudogene (RN7SL43P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call